The New Rulebook: What's Changing?
The core of the change lies in the Cosmetics Rules, 2020, which are now being more strictly enforced and amended. Under these regulations, it is mandatory for all cosmetic products—whether imported or manufactured in India—to be registered with the Central
Drugs Standard Control Organisation (CDSCO) before they can be sold. This involves submitting a detailed application through the online SUGAM portal, including product ingredients, manufacturing details, and safety data. For imported cosmetics, this process requires an application (Form COS-1) to be filed by an authorised agent in India on behalf of the foreign manufacturer, ensuring every product has a local entity accountable for it. This is a significant departure from a previously less regulated environment, creating a formal gateway that all products must pass through.
Slowing Down the Hype Cycle
For years, the Indian beauty market thrived on speed. A new 'holy grail' serum trending on social media could appear on e-commerce sites and in stores relatively quickly. The new registration-first model fundamentally alters this dynamic. The process of compiling documentation, submitting it to the CDSCO, and awaiting an import registration certificate can take around two to three months, if not longer. This mandatory waiting period acts as a buffer, making it harder for brands to capitalise on fleeting, trend-led demand. While larger, established companies with planned launch calendars can integrate this into their timelines, smaller direct-to-consumer (D2C) brands and importers that rely on agility and reacting to viral moments may find the new pace challenging. The era of seeing a TikTok trend one week and buying the product the next is likely coming to an end.
Why the Government Is Stepping In
The primary driver behind these stricter checks is consumer safety. The booming beauty market has also seen a rise in counterfeit products, unsubstantiated claims, and items containing ingredients that are not approved for cosmetic use. The regulations aim to curb these issues by creating a system of accountability. By requiring registration, the CDSCO can ensure that products meet specified quality and safety standards before they ever reach a consumer. Recent clarifications in 2026 have further tightened the screws, explicitly stating that cosmetics cannot be sold as injectables or make medical claims, targeting a grey area of 'cosmeceuticals' and aesthetic treatments. This move aligns India's regulatory framework more closely with international standards, fostering a more transparent and trustworthy market.
The Impact on Brands and Importers
The effect of these rules is not uniform across the industry. For major multinational brands, these compliance steps are standard operating procedure in most markets. However, for smaller Indian D2C brands and independent importers, the changes introduce new hurdles. The cost and administrative burden of registration, documentation, and mandatory batch-wise testing can be significant. Furthermore, the introduction of the 'new cosmetic' category—for products with novel ingredients not used anywhere else—requires an even more rigorous approval process with safety and efficacy data. This could stifle innovation among smaller players who lack the resources for extensive clinical testing. The regulations essentially professionalise the market, potentially squeezing out agile but less-resourced brands who thrived on speed-to-market.
What This Means for Beauty Shoppers
For the average consumer, these changes bring both pros and cons. The most significant benefit is the assurance of safety and quality. When you buy a registered product, you can be more confident that it is genuine and has been vetted by a regulatory authority. It also means clearer labelling and accountability if a product causes issues. The downside is potentially reduced choice and slower access to global trends. That niche Korean sunscreen or viral foundation from an indie US brand might take much longer to be officially available in India, if at all. There is also a possibility that brands may pass on the increased costs of compliance to the consumer, leading to slightly higher prices. It's a trade-off: a more curated and safe selection, but perhaps a less spontaneous and trend-driven one.
